Open-label study of Equetro [carbamazepine ER] for the treatment of mania in children ages 6-12 with bipolar I, bipolar II, and bipolar spectrum disorder.

Trial Profile

Open-label study of Equetro [carbamazepine ER] for the treatment of mania in children ages 6-12 with bipolar I, bipolar II, and bipolar spectrum disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jun 2010

At a glance

  • Drugs Carbamazepine (Primary)
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Feb 2009 Actual number of patients (33) added as reported by ClinicalTrials.gov.
    • 10 Jun 2008 Status change from recruiting to completed, according to clinicaltrials.gov.
    • 17 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top